# Elevate Health Technologies — OnePulse Connect

> Elevate Health Technologies helps specialty medical practices run in-office infusion and medically integrated dispensing (MID) through OnePulse Connect — a platform and clinical program covering infusion-suite operations, nursing, DSCSA-compliant supply chain, and buy-and-bill billing. The pages below focus on in-office infusion for neurology practices in the United States.

## Primary page
- [In-Office Infusion for Neurology Practices](https://www.elevateht.com/neurology-infusion): How neurology practices keep infusion patients in their own office — IVIG, MS biologics, and Alzheimer's antibody therapies — on the physician-chosen product, monitored by the practice's own team. OnePulse Connect sets up and runs the program end to end, whether the practice is starting infusion or growing an existing program.

## Key concepts (plain-language definitions)
- In-office infusion (buy-and-bill): the practice acquires, administers, and bills the infused drug on-site, rather than referring patients to a hospital outpatient department, home infusion, or a white-bag pharmacy. It keeps the site of care and the site of treatment in the same place.
- Medically integrated dispensing (MID): the practice dispenses the specialty medications it prescribes as part of the same clinical program, instead of routing them to an outside pharmacy. In neurology this concerns infusion and provider-administered specialty therapies, not oral pharmacy-benefit drugs. Legality varies by U.S. state.
- White-bagging: an outside pharmacy ships a patient-specific drug to the practice; the practice cannot choose or substitute the product. IVIG products are not interchangeable, so this can change the product without physician consent.
- OnePulse Connect: the Elevate Health Technologies platform and clinical program providing suite operations, nursing protocols, supply chain, benefits investigation, prior authorization, and claim reconciliation for in-office infusion and MID.

## Conditions commonly treated in-office (neurology)
- CIDP, MMN, generalized Myasthenia Gravis (gMG), NMOSD, Multiple Sclerosis, GBS recovery, Stiff-Person Syndrome, primary immunodeficiency (CVID / XLA), dermatomyositis, ITP.

## What a practice can expect
- A no-commitment, claims-based estimate of infusion volume and buy-and-bill economics before any decision.
- The practice's state-specific regulatory path for in-office infusion and dispensing, mapped during discovery.
- Typical implementation of 60–90 days, with EMR integration, credentialing, payer enrollment, supply chain, and nursing workflows handled by Elevate Health Technologies.

## Optional
- [Elevate Health Technologies — home](https://www.elevateht.com/)
- [Book a consult](https://www.elevateht.com/neurology-infusion#consult)